Spineart is pleased to announce the first implantation of the Lateral Ti-LIFE cage JULIET®Ti LL in Australia.
Dr Ivan Bhaskar, neurosurgeon, successfully performed the procedure in St Vincent Hospital in Melbourne on November 20th, 2020.
JULIET®Ti LL is a Lateral cage featuring Ti-LIFE Technology, a structure that mimics the geometry of trabecular bone and is designed to promote bone in-growth. JULIET®Ti LL features an overall reduction in material density, that optimizes medical imaging when making postoperative evaluations.
BEST IN CLASS AWARD TO DR. JESÚS PINO FOR HIS PRESENTATION OF THE EXPERIMENTAL WORK WITH TI-LIFE TECHNOLOGY CAGES AT THE 34TH GEER
Spineart is proud to announce the “Best in class” award given to Dr. Jesús PINO for his presentation of the experimental work with Ti-LIFE Technology cages in an in vivo ovine model during the 34th GEER congress.
The experiments, which included micro-CT and CT scans along with histology, resulted in very early osseointegration of Ti-LIFE cages.
Spineart, as a science-driven company, would like to congratulate Dr. Jesús PINO for this outstanding achievement and are pleased to be associated with this important development. We are committed to improving spine care by evidence-based medicine and engineering and look forward to other great news to come in 2021.
Spineart is happy to be joining with Hotel Management International (HMI) in supporting the Geneva Red Cross this holiday season. In this particularly challenging year the Geneva Red Cross has needed donations more than ever. The donations of gifts will go towards creating Christmas baskets, which will be distributed to people in need. Spineart believes in the importance of helping others as together we can achieve so much more.
Following its success in the US and Europe, Spineart is proud to announce the first Australian surgical case using PERLA® TL, the new Posterior Thoracolumbar Fixation System.
On November 18th 2020, Dr. Neil COCHRANE from Sunnybank, QLD performed the first Australian spine surgery using PERLA® TL.
Dr. COCHRANE commented on the system that, “PERLA® TL was a straight-forward, solid, smooth and robust system that was a joy to use. Well done!“
PERLA® TL Posterior Thoraco-Lumbar Fixation system combines a compact set of simplified instrumentation with smart instrument design. The system offers a complete range of sterile-packed bar-coded implants, including pedicle screws with the following innovative features: a Dual Core Dual Thread Screw Shaft design and a Friction Tulip Head compatible with two rod diameters.
Spineart is proud to have hosted our first face-to-face event of 2020 in China!
The Cervical Spine Arthroplasty Expert Summit was held in Nanchang on 29th Nov 2020, involving more than 40 participants.
During this highly interactive meeting, the participants learned about the history of cervical arthroplasty and were introduced to the latest NMPA (National Medical Products Administration) approved arthroplasty device: BAGUERA® C.
A combination of presentations on case studies and clinical results, discussion forums on complications, and live surgery gave the participants a deep understanding of the patient benefits, the indications, the surgical steps and pitfalls to avoid when implanting an arthroplasty device.
The participants enjoyed being able to use the opportunity of the highly professional learning environment to meet together in a more relaxed setting.
En este año único, Spineart se enorgullece de ser patrocinador del congreso GEER una vez más y brindarle la oportunidad de descubrir nuestro stand virtual. Descubra la gama de nuestros productos básicos, nuestros productos más vendidos y nuestras últimas innovaciones. Nos complace compartir que el Dr. Pino presentará los hallazgos del estudio Ti-LIFE en modelo in vivo.
In this unique year, Spineart is proud to sponsor GEER once again giving you the opportunity to discover our virtual booth. Discover our extensive product portfolio including our essentials, our best-sellers and our latest innovations. We’re excited to inform you that the results from our Ti-LIFE animal study will be presented by Dr. Pino.